DiscoverBreakthroughsMeeting the challenge of Antimicrobial Resistance (AMR)
Meeting the challenge of Antimicrobial Resistance (AMR)

Meeting the challenge of Antimicrobial Resistance (AMR)

Update: 2023-05-102
Share

Description

Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK, to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.

 

PP-UNP-GBR-4716 / May 2023

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Meeting the challenge of Antimicrobial Resistance (AMR)

Meeting the challenge of Antimicrobial Resistance (AMR)

Pfizer